Btr Capital Management Inc Pfizer Inc Transaction History

Btr Capital Management Inc

$641 Million
Q3 2022

A detailed history of Btr Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Btr Capital Management Inc holds 360,859 shares of PFE stock, worth $9.65 Million. This represents 2.46% of its overall portfolio holdings.

Number of Shares

360,859

Previous 352,219 2.45%

Holding current value

$9.65 Million

Previous $18.5 Million 14.49%

% of portfolio

2.46%

Previous 2.65%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 12, 2022	BUY	$43.76 - $53.42 $378,086 - $461,548	8,640 Added 2.45%	360,859 $15.8 Million
Q2 2022 Jul 12, 2022	SELL	$46.53 - $55.17 $54,672 - $64,824	-1,175 Reduced 0.33%	352,219 $18.5 Million
Q1 2022 May 02, 2022	BUY	$45.75 - $56.69 $3,751 - $4,648	82 Added 0.02%	353,394 $18.3 Million
Q4 2021 Feb 02, 2022	BUY	$41.32 - $61.25 $84,044 - $124,582	2,034 Added 0.58%	353,312 $20.9 Million
Q3 2021 Oct 18, 2021	BUY	$39.25 - $50.42 $18,015 - $23,142	459 Added 0.13%	351,278 $15.1 Million
Q2 2021 Aug 02, 2021	BUY	$35.91 - $40.68 $307,748 - $348,627	8,570 Added 2.5%	350,819 $13.7 Million
Q1 2021 Apr 08, 2021	BUY	$33.49 - $37.77 $1.72 Million - $1.94 Million	51,372 Added 17.66%	342,249 $12.4 Million
Q4 2020 Jan 12, 2021	BUY	$33.47 - $42.56 $563,099 - $716,029	16,824 Added 6.14%	290,877 $10.7 Million
Q3 2020 Oct 15, 2020	BUY	$31.75 - $37.25 $377,761 - $443,200	11,898 Added 4.54%	274,053 $10.1 Million
Q2 2020 Jul 23, 2020	BUY	$30.12 - $36.54 $55,993 - $67,927	1,859 Added 0.71%	262,155 $8.57 Million
Q1 2020 Apr 21, 2020	BUY	$27.03 - $38.62 $543,140 - $776,030	20,094 Added 8.37%	260,296 $8.5 Million
Q4 2019 Jan 17, 2020	BUY	$32.92 - $37.36 $377,493 - $428,407	11,467 Added 5.01%	240,202 $9.41 Million
Q3 2019 Oct 21, 2019	BUY	$32.49 - $42.13 $1.04 Million - $1.35 Million	31,949 Added 16.24%	228,735 $7.8 Million
Q2 2019 Jul 18, 2019	BUY	$36.98 - $41.52 $79,728 - $89,517	2,156 Added 1.11%	196,786 $8.53 Million
Q1 2019 Apr 04, 2019	SELL	$37.5 - $41.2 $350,587 - $385,178	-9,349 Reduced 4.58%	194,630 $0
Q4 2018 Jan 23, 2019	SELL	$38.47 - $43.86 $485,260 - $553,250	-12,614 Reduced 5.82%	203,979 $8.9 Million
Q3 2018 Oct 04, 2018	SELL	$34.47 - $41.81 $1.23 Million - $1.49 Million	-35,560 Reduced 14.1%	216,593 $9.55 Million
Q2 2018 Aug 01, 2018	SELL	$32.98 - $35.16 $10,058 - $10,723	-305 Reduced 0.12%	252,153 $9.15 Million
Q1 2018 May 01, 2018	SELL	$31.91 - $37.02 $16,912 - $19,620	-530 Reduced 0.21%	252,458 $8.96 Million
Q4 2017 Jan 31, 2018	SELL	$33.26 - $35.29 $102,174 - $108,410	-3,072 Reduced 1.2%	252,988 $9.16 Million
Q3 2017 Oct 27, 2017	BUY	$31.0 - $34.15 $7.94 Million - $8.74 Million	256,060	256,060 $9.14 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Btr Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Btr Capital Management Inc with notifications on news.

Account

Btr Capital Management Inc Pfizer Inc Transaction History